Antibody Characterization Balances Rigor and Reason
Emphasizes a Combination of Antibody-Dependent and -Independent Testing Methods
Cancer Immunotherapy Spurs Work on Better Animal Models
GEN Spoke to Several Researchers on Advances in Engineered Animal Models Used to Study Novel Cancer Im-munotherapies
The Rise of Single-Cell Genomics
The Ability to Profile Single Whole Cells and Single Nuclei Will Also Help Shape Understanding of Each Cell Type
Philadelphia Project Gains STEAM
Artists Partner with Biotech to Inspire Young Scientists
Bioethics of GM Humans
The Journal of the Royal Society of Medicine recently published two opposing viewpoints on the ethics of using gene-editing technology human embryos. One article, written by an actress who has a rare form of dwarfism, maintains that gene editing does not represent a benefit to healthcare. The other, written by an Oxford research fellow, makes the case that while gene editing is not without controversy it should be developed.
The first author makes the point that social inequality would increase between those who were and were not genetically modified. While the second author makes the distinction that gene editing embryos is about modifying life where it already existed versus artificial selection which chooses which embryo is allowed to continue developing.